R & D systems - custom trocriscreen - 594 compounds, 5MG each - quote #BT-1922491
Ended Awarded
- Contract number
- HHSN31900001
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $21,419
Award facts
- Contract value 100% obligated
- $21,418.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a $21,418.90 firm fixed-price call against a Blanket Purchase Agreement (BPA) by the National Center for Advancing Translational Sciences on June 24, 2014. The contract covers the supply of a custom TrocrIScreen compound library consisting of 594 compounds at 5 milligrams each, to be delivered by August 31, 2014. This award was made through open competition with no set-aside designation and represents a task order fulfillment under R&D Systems' existing $10 million BPA with the Office of Logistics and Acquisition Operations, which supports biomedical research across multiple National Institutes of Health institutes through September 30, 2025.
R&D Systems specializes in providing high-quality biological research materials, including recombinant proteins, antibodies, and specialized research reagents critical to federal research programs. The National Center for Advancing Translational Sciences, which supports the translation of laboratory discoveries into clinical applications, regularly procures custom screening libraries and research compounds from established suppliers like R&D Systems to facilitate drug discovery and disease research initiatives. This contract exemplifies the company's role as a key supplier within the NIH ecosystem, delivering specialized scientific materials that enable translational research across various medical and scientific disciplines.
Quick answers
Who was awarded contract HHSN31900001?
HHSN31900001 was awarded to Research And Diagnostic Systems, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on June 24, 2014.
How much is contract HHSN31900001 worth?
The government has obligated $21,419 on HHSN31900001.
Is contract HHSN31900001 an order under another contract?
Yes. HHSN31900001 is a BPA call under HHSN263199900050140B, a blanket purchase agreement.
Was contract HHSN31900001 competed?
The extent of competition for HHSN31900001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award